Bluefin Capital Management’s Gilead Sciences GILD Stock Holding History

Bluefin Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-57,400	Closed	-$276K	–	571
2022 Q3	$276K	Hold	57,400	–	–	0.03%	243
2022 Q2	$326K	Hold	57,400	–	–	0.04%	222
2022 Q1	$265K	Hold	57,400	–	–	0.02%	290
2021 Q4	$864K	Hold	57,400	–	–	0.06%	243
2021 Q3	$786K	Hold	57,400	–	–	0.08%	189
2021 Q2	$672K	Hold	57,400	–	–	0.04%	235
2021 Q1	$552K	Buy	+57,400	New	+$3.7M	0.03%	280
2020 Q3	–	Sell	-10,000	Closed	-$26K	–	513
2020 Q2	$26K	Buy	+10,000	New	+$766K	﹤0.01%	326
2019 Q1	–	Sell	-98,200	Closed	-$1K	–	441
2018 Q4	$1K	Buy	+98,200	New	+$6.86M	﹤0.01%	403
2016 Q1	–	Sell	-11,500	Closed	-$52K	–	569
2015 Q4	$52K	Sell	11,500 -421,700	-97%	-$43.9M	﹤0.01%	505
2015 Q3	$18K	Buy	433,200 +79,000	+22%	+$8.77M	﹤0.01%	443
2015 Q2	$1.91M	Buy	354,200 +303,200	+595%	+$33.1M	0.12%	150
2015 Q1	$219K	Buy	51,000 +18,500	+57%	+$1.88M	0.02%	371
2014 Q4	$81K	Sell	32,500 -42,300	-57%	-$4.37M	﹤0.01%	583
2014 Q3	$294K	Buy	+74,800	New	+$7.32M	0.02%	504

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bluefin Capital Management's GILD Position: Q1 2026 in Review

Bluefin Capital Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 7,900 shares — an estimated $970K sold.

Bluefin Capital Management first reported a position in GILD in Q2 2013 and held it in 32 quarters. The position peaked at $21.7M in Q1 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Bluefin Capital Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Bluefin Capital Management sold 7,900 Gilead Sciences shares in Q1 2026, an estimated $970K.
Bluefin Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 32 quarters.
Bluefin Capital Management's Gilead Sciences position peaked at $21.7M in Q1 2015.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bluefin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.